About Ajit Laboratories Limited
Data last updated:
Ajit Laboratories Limited is a private limited company based in Sangli, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 1949 and has been in existence for over 77 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN1949PTC007807. Its GSTIN is 27AACCA2039E1Z5 (Maharashtra).
The company has an authorised share capital of ₹2.5 Lakh and a paid-up capital of ₹1.4 Lakh. It is led by directors including Avadhoot Sanjay Kulkarni and Aniruddha Shreedhar Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Matrukripa Industrial Estatearea Sangli – Miraj Road, Maharashtra, India – 416410.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹4,997 (net margin 0%) and EBITDA of ₹77,780 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹4.35 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ajitlabs.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressMatrukripa Industrial Estatearea Sangli – Miraj Road, Maharashtra, India – 416410
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ajit Laboratories Limited
The main business activity of Ajit Laboratories is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ajit Laboratories Limited FY 2025 filings available
Ajit Laboratories Limited reported revenue of ₹1.11 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ajit Laboratories Limited
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 6% growth in the latest year. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ajit Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹77,780 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4,997 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ajit Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ajit Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ajit Laboratories Limited
Ajit Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Ars India Labs Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Madurai, Tamil Nadu, India |
| Ilex Biologicals Private Limited | ₹1.11 Cr (FY 2023) | •••• | •••• | 21.0% | •••• | Greater Noida, Uttar Pradesh, India |
| God Jay Laboratories Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Delhi, India |
| Gilman Laboratories Pvt Ltd | ₹1.11 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Secunderabad, Telangana, India |
| Walfs Pharma Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Chennai, Tamil Nadu, India |
| Ajit Laboratories Limited this company | ₹1.11 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Sangli, Maharashtra, India |
| Biocare Remedies Pvt Ltd | ₹1.1 Cr (FY 2024) | •••• | •••• | •••• | Gandhinagar, Gujarat, India | |
| Khevo Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Pune, Maharashtra, India |
| Neuheit Pharma Private Limited | ₹1.1 Cr (FY 2020) | •••• | •••• | 935.0% | •••• | Hyderabad, Telangana, India |
| Lindsay Pharmaceutical Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Patna, Bihar, India |
| Zeuson Medicines Private Limited | ₹1.1 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Ajit Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ajit Laboratories Limited
Ajit Laboratories Limited is audited by ABHYANKAR & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABHYANKAR & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ajit Laboratories Limited
Ajit Laboratories has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avadhoot Sanjay Kulkarni | Director | 30 Sep 2019 | 7 Years 0 Months | Current |
| Aniruddha Shreedhar Kulkarni | Director | 30 Sep 2019 | 7 Years 0 Months | Current |
| Amruta Padmanabh Joshi | Director | 30 Sep 2019 | 7 Years 0 Months | Current |
| Uday Mukundrao Kulkarni | Director | 23 Mar 1987 | 39 Years 6 Months | Current |
| Abhijit Uday Kulkarni | Director | 21 May 2009 | 17 Years 4 Months | Current |
| Anjali Uday Kulkarni | Director | 23 Mar 1987 | 39 Years 6 Months | Current |
Ownership and Shareholding of Ajit Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ajit Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2000 | Union Bank of India | ₹75,000 | Open |
| 28 Jun 1995 | Union Bank of India | ₹1.5 Lakh | Open |
| 20 Nov 1991 | Union Bank of India | ₹1.1 Lakh | Open |
| 22 Oct 1991 | Union Bank of India | ₹1 Lakh | Open |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Ajit Laboratories Limited
Employment history and EPFO contributions of people linked to Ajit Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Ajit Laboratories Limited
Ajit Laboratories has one previous CIN (Corporate Identification Number): U24231MH1949PLC007807. The current CIN is U24231PN1949PTC007807, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231PN1949PTC007807 | Current |
| U24231MH1949PLC007807 | Previous |
Recent Activity on Ajit Laboratories Limited
Ajit Laboratories Limited has 7 board changes on record since 1987: 6 appointments and 1 cessation. The latest: Amruta Padmanabh Joshi was appointed as Director on 30 Sep 2019.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ajit Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ajit Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ajit Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ajit Laboratories Limited
Ajit Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCA2039E1Z5 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ajit Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajit Laboratories Limited
Ajit Laboratories is an active private limited company based in Sangli, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 1949 (77+ years old) and is registered under CIN U24231PN1949PTC007807.
Ajit Laboratories reported revenue of ₹1.11 Cr for FY 2025 (up 6% YoY).
Ajit Laboratories has 6 current directors:
- Avadhoot Sanjay Kulkarni - Director
- Aniruddha Shreedhar Kulkarni - Director
- Amruta Padmanabh Joshi - Director
- Uday Mukundrao Kulkarni - Director
- Abhijit Uday Kulkarni - Director
- Anjali Uday Kulkarni - Director
Ajit Laboratories reported a net profit of ₹4,997 (net margin 0%) and EBITDA of ₹77,780 (EBITDA margin 0.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ajit Laboratories is 10% over three years and 22% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ajit Laboratories is 27AACCA2039E1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ajit Laboratories is U24231PN1949PTC007807. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ajit Laboratories was incorporated on 04 October 1949, making it 77+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Ajit Laboratories by revenue are Dr. Ars India Labs Private Limited, Ilex Biologicals Private Limited, God Jay Laboratories Private Limited, Gilman Laboratories Pvt Ltd, Walfs Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Amruta Padmanabh Joshi was appointed as Director on 30 Sep 2019. Aniruddha Shreedhar Kulkarni was appointed as Director on 30 Sep 2019. Avadhoot Sanjay Kulkarni was appointed as Director on 30 Sep 2019. Ajit Laboratories has 7 board changes on record in total.
Ajit Laboratories can be reached through the website ajitlabs.co.in. Its registered office is in Sangli, Maharashtra, India.